---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-228351"
form_type: "8-K"
ticker: "ENGN"
cik: "0001980845"
company_name: "enGene Therapeutics Inc."
filed_at: "2025-10-02T23:59:59+00:00"
generated_at: "2026-05-17T04:58:17.670070+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# enGene amends CEO Ron Cooper's severance to 1.5x target bonus on change-in-control termination

## Summary
- Board approved amendment to Cooper Employment Agreement, effective October 2, 2025.
- CIC termination severance multiplier increased from 1.0x to 1.5x annual target bonus.
- Lump sum payment payable within 45 days of CIC termination, subject to compliance.
- Amendment recommended by Compensation Committee; full text to be filed in 10-K for FY ending Oct 31, 2025.

## SEC filing metadata
- accession: 0001193125-25-228351
- form_type: 8-K
- ticker: ENGN
- cik: 0001980845
- company_name: enGene Therapeutics Inc.
- filed_at: 2025-10-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1980845/000119312525228351/0001193125-25-228351-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1980845/000119312525228351/engn-20251002.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-228351
- JSON: https://secwatch.observer/filing/0001193125-25-228351.json
- Plain text: https://secwatch.observer/filing/0001193125-25-228351.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.